{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:05:44Z","timestamp":1761239144659},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/Aims<\/jats:title>\n                <jats:p>Chronic constipation (CC) is one of the most common gastrointestinal disorders in the general population. Although there are many treatment options, achieving a stable treatment for CC remains one of the challenges in clinical practice. This study aimed to evaluate the clinical factors associated with stable treatment for CC in Japanese patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective, cross-sectional, and multicenter study was carried out. Patients were eligible for inclusion if they fulfilled the Rome IV criteria for diagnosing CC and had been treated for at least one and a half years. Patients with up to two prescription modifications for CC in one year were defined as the stable treatment group, whereas those with three or more prescription changes were defined as the unstable treatment group. Univariate and multivariate analyses were carried out to identify factors associated with CC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 114 patients have been recruited. There were 82 patients (77.0%) in the stable treatment group and 32 patients (23.0%) in the unstable treatment group. Based on multivariate likelihood analysis, only using acid-suppressive drugs contributed to stability treatment in CC patients (odds ratio: 2.81, 95% confidence interval: 1.12\u20137.08, <jats:italic>p<\/jats:italic>\u2009=\u20090.03).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Administration of acid-suppressive drugs was the only factor related to the stability of CC treatment. Further studies are needed to validate the results as well as clarify the causes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-024-03140-y","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T12:02:44Z","timestamp":1706529764000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical factors associated with stable treatment of chronic constipation in Japanese patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Kazuki","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nhu Thi Hanh","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirona","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomitsu","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc Trong","family":"Quach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"issue":"9","key":"3140_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/ajg.2011.164","volume":"106","author":"NC Suares","year":"2011","unstructured":"Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(9):1582\u201391. quiz 1581, 1592.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3140_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.5056\/jnm15187","volume":"22","author":"A Tamura","year":"2016","unstructured":"Tamura A, Tomita T, Oshima T, Toyoshima F, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Ikehara H, et al. Prevalence and self-recognition of chronic constipation: results of an internet survey. J Neurogastroenterol Motil. 2016;22(4):677\u201385.","journal-title":"J Neurogastroenterol Motil"},{"issue":"8","key":"3140_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00535-017-1428-9","volume":"53","author":"M Ono","year":"2018","unstructured":"Ono M, Kato M, Miyamoto S, Tsuda M, Mizushima T, Ono S, Nakagawa M, Mabe K, Nakagawa S, Muto S, et al. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan. J Gastroenterol. 2018;53(8):916\u201323.","journal-title":"J Gastroenterol"},{"key":"3140_CR4","volume-title":"Evidence-based clinical practice guidelines for chronic constipation 2017, ed. Research society for the diagnosis and treatment of chronic constipation, affiliated to the Japanese Society of Gastroenterology in Japanese","author":"Gastroenterology","year":"2017","unstructured":"Gastroenterology, JSo. Evidence-based clinical practice guidelines for chronic constipation 2017, ed. Research society for the diagnosis and treatment of chronic constipation, affiliated to the Japanese Society of Gastroenterology in Japanese. Tokyo: Nankodo Co, Ltd; 2017."},{"issue":"9","key":"3140_CR5","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s10620-011-1639-5","volume":"56","author":"SX Sun","year":"2011","unstructured":"Sun SX, Dibonaventura M, Purayidathil FW, Wagner JS, Dabbous O, Mody R. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci. 2011;56(9):2688\u201395.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"3140_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cgh.2014.08.026","volume":"13","author":"S Fukudo","year":"2015","unstructured":"Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol. 2015;13(2):294\u2013301e295.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3140_CR7","doi-asserted-by":"publisher","first-page":"e13487","DOI":"10.1111\/nmo.13487","volume":"31","author":"S Fukudo","year":"2019","unstructured":"Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako M, Hayashi K, Akiho H, Kuroishi K, Johnston JM, Currie M, et al. High-dose linaclotide is effective and safe in patients with chronic constipation: a phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. Neurogastroenterol Motil. 2019;31(1):e13487.","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"3140_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(18)30123-7","volume":"3","author":"A Nakajima","year":"2018","unstructured":"Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(8):537\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"3140_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"3140_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.clinthera.2021.03.021","volume":"43","author":"CL Morgan","year":"2021","unstructured":"Morgan CL, Jenkins-Jones S, Knaggs R, Currie C, Conway P, Poole CD, Berni E. Characterization and Associated costs of Constipation relating to exposure to strong opioids in England: an observational study. Clin Ther. 2021;43(6):968\u201389.","journal-title":"Clin Ther"},{"key":"3140_CR11","unstructured":"Obesity JSftSo.: Guidelines for the management of obesity disease 2016. In.: Life Science Publishing Tokyo; 2016."},{"issue":"3","key":"3140_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/2050640615600114","volume":"4","author":"N Vakil","year":"2016","unstructured":"Vakil N, Stelwagon M, Shea EP, Miller S. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United Eur Gastroenterol J. 2016;4(3):413\u201322.","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"3140_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.5056\/jnm17033","volume":"23","author":"KS Park","year":"2017","unstructured":"Park KS, Jee SR, Lee BE, Hong KS, Shin JE, Na SY, Kwon JG, Choi SC, Kim YS, Lee HS, et al. Nationwide Multicenter Study for overlaps of Common Functional Gastrointestinal disorders in Korean patients with constipation. J Neurogastroenterol Motil. 2017;23(4):569\u201377.","journal-title":"J Neurogastroenterol Motil"},{"issue":"11","key":"3140_CR14","first-page":"Cd011194","volume":"11","author":"MI Pinto-Sanchez","year":"2017","unstructured":"Pinto-Sanchez MI, Yuan Y, Hassan A, Bercik P, Moayyedi P. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017;11(11):Cd011194.","journal-title":"Cochrane Database Syst Rev"},{"key":"3140_CR15","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006(4):Cd001960.","DOI":"10.1002\/14651858.CD001960.pub3"},{"issue":"2","key":"3140_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/br.2016.828","volume":"6","author":"D Asaoka","year":"2017","unstructured":"Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, et al. Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. Biomed Rep. 2017;6(2):175\u201380.","journal-title":"Biomed Rep"},{"issue":"3","key":"3140_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/tropej\/fmp077","volume":"56","author":"NM Devanarayana","year":"2010","unstructured":"Devanarayana NM, Rajindrajith S. Association between constipation and stressful life events in a cohort of Sri Lankan children and adolescents. J Trop Pediatr. 2010;56(3):144\u20138.","journal-title":"J Trop Pediatr"},{"issue":"2","key":"3140_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3810\/pgm.2013.03.2640","volume":"125","author":"D Nellesen","year":"2013","unstructured":"Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med. 2013;125(2):40\u201350.","journal-title":"Postgrad Med"},{"issue":"5","key":"3140_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrgastro.2009.35","volume":"6","author":"SH Rhee","year":"2009","unstructured":"Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6(5):306\u201314.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"3140_CR20","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203\u20139.","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"3140_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2741\/3603","volume":"15","author":"EB Troy","year":"2010","unstructured":"Troy EB, Kasper DL. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci (Landmark Ed). 2010;15(1):25\u201334.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"7","key":"3140_CR22","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.1010529108","volume":"108","author":"R Diaz Heijtz","year":"2011","unstructured":"Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bj\u00f6rkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3140_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrmicro2973","volume":"11","author":"M Blaser","year":"2013","unstructured":"Blaser M, Bork P, Fraser C, Knight R, Wang J. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol. 2013;11(3):213\u20137.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"3140_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12263-011-0229-7","volume":"6","author":"J Gerritsen","year":"2011","unstructured":"Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011;6(3):209\u201340.","journal-title":"Genes Nutr"},{"issue":"4","key":"3140_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/107602960100700416","volume":"7","author":"IV Kirgizov","year":"2001","unstructured":"Kirgizov IV, Sukhorukov AM, Dudarev VA, Istomin AA. Hemostasis in children with dysbacteriosis in chronic constipation. Clin Appl Thromb Hemost. 2001;7(4):335\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"3140_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740\u20138.","journal-title":"Gut"},{"issue":"5","key":"3140_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Goodrich JK, Maxan ME, Freedberg DE, Abrams JA, Poole AC, Sutter JL, Welter D, Ley RE, Bell JT, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65(5):749\u201356.","journal-title":"Gut"},{"issue":"4","key":"3140_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","volume":"149","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Toussaint NC, Chen SP, Ratner AJ, Whittier S, Wang TC, Wang HH, Abrams JA. Proton Pump inhibitors alter specific Taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015;149(4):883\u2013885e889.","journal-title":"Gastroenterology"},{"issue":"3","key":"3140_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5056\/jnm15094","volume":"21","author":"EM Quigley","year":"2015","unstructured":"Quigley EM. Prokinetics in the management of Functional Gastrointestinal disorders. J Neurogastroenterol Motil. 2015;21(3):330\u20136.","journal-title":"J Neurogastroenterol Motil"},{"issue":"1","key":"3140_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.gastro.2012.10.028","volume":"144","author":"AE Bharucha","year":"2013","unstructured":"Bharucha AE, Pemberton JH, Locke GR. 3rd: American Gastroenterological Association technical review on constipation. Gastroenterology. 2013;144(1):218\u201338.","journal-title":"Gastroenterology"},{"key":"3140_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-444-53491-0.00022-5","volume":"117","author":"AI Vinik","year":"2013","unstructured":"Vinik AI, Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol. 2013;117:279\u201394.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"3140_CR32","first-page":"66","volume":"11","author":"SH Han","year":"2005","unstructured":"Han SH, Lee OY, Lee YS, Kim KB, Yoon BC, Choi HS. Anxiety, depression and sleep disturbance in female constipation predominant irritable bowel syndrome. Kor J Neurogastroenterol Motil. 2005;11(1):66\u201371.","journal-title":"Kor J Neurogastroenterol Motil"},{"issue":"3","key":"3140_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1365-2036.2003.01663.x","volume":"18","author":"C Cheng","year":"2003","unstructured":"Cheng C, Chan AO, Hui WM, Lam SK. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther. 2003;18(3):319\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"3140_CR34","doi-asserted-by":"crossref","unstructured":"Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 2012;10(5):494\u2013500.","DOI":"10.1016\/j.cgh.2011.12.041"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03140-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03140-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03140-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T04:48:13Z","timestamp":1706676493000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03140-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3140"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03140-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Hiroshima University (Approval No. 4090). The study was conducted in accordance with the Declaration of Helsinki by the World Medical Association. Due to the retrospective character of the study, informed consent was waived by the Ethical Committee of Hiroshima University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}